MORRISVILLE, N.C.--(BUSINESS WIRE)--Dr. Mark Sirgo, BDSI’s (Nasdaq: BDSI) President and CEO, will present at Maxim Group’s First Annual Growth Conference on September 20, 2007 at the Grand Hyatt Hotel located in New York City at 3:00pm. Dr. Sirgo will highlight the company’s strategy resulting from the recent closing of the partnership agreement with Meda AB for the US distribution rights to BEMA™ Fentanyl, the company’s flagship product along with plans for the development of the other products in BDSI’s pipeline including BEMA LA.
